Tolerability and Quality of Life Study in Participants Who Switched to Avonex Pen

Clinical trial NCT02076841 · COMPLETED

Trial details

NCT number: NCT02076841
Sponsor: Biogen
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-Remitting Multiple Sclerosis Clinical Isolated Syndrome (CIS)Multiple Sclerosis

Start date: 2013-07-01
Primary completion: 2016-02-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.